Impact of sarcopenia in lenvatinib treatment for hepatocellular carcinoma; A prospective observational study
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000033757
- Lead Sponsor
- Saiseikai Maebashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Child-Pugh class B or C 2)Performance status 2 or more 3)Patients with obvious invasion of the bile duct, or invasion at the main portal vein 4)Patients with 50% or higher liver occupation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method